Actionable insights straight to your inbox

logo_equities.svg

AstraZeneca To Acquire Alexion Pharmaceuticals for $39 Billion

The deal will be AstraZeneca's largest acquisition, helping it to diversify from its fast-growing cancer business into rare diseases and immunology.